[Treatment of chronic respiratory insufficiency of pulmonary origin. Clinical considerations].
The key-points of the physiopathological treatment of chronic pneumogenous respiratory insufficiency are: correction of distribution defects, suitable local adjustment of the ventilation: perfusion ratio, and correction of obstacles to alveolocapillary diffusion. Many drugs can be used to obtain these results; bronchodilators, vasoactive drugs, cortisones, cardiokinetics, antibiotics, analeptics. Reference is also made to oxygen therapy, depletion management (bloodletting and-or diuretics, and their possible mechanisms. Lastly, attention is given to disturbances, in acid-base equilibrium in chronic respiratory insufficiency and their correction.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D001815:Bloodletting; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D010102:Oxygen Inhalation Therapy; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D013566:Sympathomimetics / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D011459:Prostaglandins E, Synthetic; D013566:Sympathomimetics; D001285:Atropine; D004205:Cromolyn Sodium
La terapia dell'insufficienza respiratoria cronica pneumogena. Considerazioni cliniche.